Traditional Chinese Medicine Applications in Esophageal Cancer Treatment

Traditional Chinese Medicine (TCM) offers a multifaceted approach to esophageal cancer management, integrating botanical extracts, injectable formulations and herbal decoctions as adjuvant or standalone therapies. Research spans preclinical investigations of anti-tumour and anti-metastatic activity, bioinformatic elucidation of molecular targets and systematic evaluations of clinical outcomes when TCM is combined with surgery, radiotherapy or chemotherapy. Key mechanisms include induction of apoptosis, inhibition of invasion-related enzymes, modulation of immune function and enhancement of patient quality of life. Modern analyses harness network pharmacology and gene co-expression profiling to reveal how complex herbal mixtures engage signalling pathways such as PI3K–Akt and ErbB, while clinical meta-analyses rank the relative efficacy and safety of specific injections. Together, these efforts highlight TCM’s potential to improve treatment response, reduce toxicity and identify novel biomarkers for precision care.

Research from Nature Portfolio

Preclinical work on Andrographis paniculata water extract demonstrated potent anti-metastatic effects in oesophageal cancer xenografts, suppressing factors such as HER2, MMP2 and CXCR4, and acting synergistically with cisplatin plus 5-fluorouracil to inhibit tumour nodules while mitigating chemotherapy-induced side-effects. Complementing these findings, an integrated bioinformatics study applied weighted gene co-expression network analysis alongside network pharmacology to Compound Kushen injection. Key hub targets including EGFR, ErbB2, CCND1 and IGF1R were identified, with molecular docking confirming strong binding of active compounds. Pathway enrichment pointed to modulation of PI3K–Akt and ErbB signalling, providing a mechanistic basis for CKI’s clinical efficacy.

Traditional Chinese Medicine Applications in Esophageal Cancer Treatment publication trend

The graph below shows the total number of articles in traditional chinese medicine applications in esophageal cancer treatment across all publications each year (not limited to Nature Index journals).

Technical terms

Andrographis paniculata: A medicinal herb whose extract exhibits anti-tumour and anti-metastatic properties.

Compound Kushen injection (CKI): A standardised herbal formulation used clinically to enhance anti-cancer efficacy and reduce toxicity.

Weighted gene co-expression network analysis (WGCNA): A bioinformatic method for identifying gene modules correlated with disease traits.

Network pharmacology: An approach combining systems biology and pharmacology to map interactions between multiple compounds and molecular targets.

Bayesian network meta-analysis: A statistical technique that compares and ranks multiple treatments using both direct and indirect evidence.

Surface under the cumulative ranking curve (SUCRA): A metric that quantifies the probability that a treatment is among the most effective options.

References

1. The Optimal Chinese Herbal Injections for Use With Radiotherapy to Treat Esophageal Cancer: A Systematic Review and Bayesian Network Meta-Analysis. Frontiers in Pharmacology (2019).
2. The adjuvant value of Andrographis paniculata in metastatic esophageal cancer treatment – from preclinical perspectives. Scientific Reports (2017).
3. Integrated bioinformatics analysis to decipher molecular mechanism of compound Kushen injection for esophageal cancer by combining WGCNA with network pharmacology. Scientific Reports (2020).
4. Natural Products for Esophageal Cancer Therapy: From Traditional Medicine to Modern Drug Discovery. International Journal of Molecular Sciences (2022).